Age patterns of HSV-2 incidence and prevalence in two Ugandan communities: a catalytic incidence model applied to population-based seroprevalence data
File(s)jiad113.pdf (707.91 KB)
Published version
Author(s)
Type
Journal Article
Abstract
Background:
Herpes simplex virus type 2 (HSV-2) is an incurable STI associated with increased risk of acquiring and transmitting HIV. HSV-2 prevalence is extremely high in sub-Saharan Africa, but population-level estimates of HSV-2 incidence are sparse. We quantified HSV-2 prevalence, risk-factors for infection, and age-patterns of incidence in south-central Uganda.
Methods:
We measured HSV-2 prevalence from cross-sectional serological data among men and women aged 18-49 in two communities (fishing/inland). We identified risk-factors for seropositivity, and inferred age-patterns of HSV-2 with a Bayesian catalytic model.
Results:
HSV-2 prevalence was 53.6% (n = 975/1819, 95%CI 51.3%-55.9%). Prevalence increased with age, was higher in the fishing community, and among women, reaching 93.6% (95%CrI 90.2%-96.6%) by age 49. Factors associated with HSV-2 seropositivity included more lifetime sexual partners, HIV positive status, and lower education. HSV-2 incidence increased steeply in late adolescence, peaking at age 18 for women and 19-20 for men. HIV prevalence was up to ten-fold higher in HSV-2-positive individuals.
Conclusions:
HSV-2 prevalence and incidence were extremely high, with most infections occurring in late adolescence. Interventions against HSV-2, such as future vaccines or therapeutics, must reach young target populations. Remarkably higher HIV prevalence among HSV-2-positive individuals underscores this population as a priority for HIV prevention.
Herpes simplex virus type 2 (HSV-2) is an incurable STI associated with increased risk of acquiring and transmitting HIV. HSV-2 prevalence is extremely high in sub-Saharan Africa, but population-level estimates of HSV-2 incidence are sparse. We quantified HSV-2 prevalence, risk-factors for infection, and age-patterns of incidence in south-central Uganda.
Methods:
We measured HSV-2 prevalence from cross-sectional serological data among men and women aged 18-49 in two communities (fishing/inland). We identified risk-factors for seropositivity, and inferred age-patterns of HSV-2 with a Bayesian catalytic model.
Results:
HSV-2 prevalence was 53.6% (n = 975/1819, 95%CI 51.3%-55.9%). Prevalence increased with age, was higher in the fishing community, and among women, reaching 93.6% (95%CrI 90.2%-96.6%) by age 49. Factors associated with HSV-2 seropositivity included more lifetime sexual partners, HIV positive status, and lower education. HSV-2 incidence increased steeply in late adolescence, peaking at age 18 for women and 19-20 for men. HIV prevalence was up to ten-fold higher in HSV-2-positive individuals.
Conclusions:
HSV-2 prevalence and incidence were extremely high, with most infections occurring in late adolescence. Interventions against HSV-2, such as future vaccines or therapeutics, must reach young target populations. Remarkably higher HIV prevalence among HSV-2-positive individuals underscores this population as a priority for HIV prevention.
Date Issued
2023-11-01
Date Acceptance
2023-04-15
Citation
Journal of Infectious Diseases, 2023, 228 (9), pp.1198-1207
ISSN
0022-1899
Publisher
Oxford University Press
Start Page
1198
End Page
1207
Journal / Book Title
Journal of Infectious Diseases
Volume
228
Issue
9
Copyright Statement
© The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of
America. This is an Open Access article distributed under the terms of the Creative Commons Attribution
License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and
reproduction in any medium, provided the original work is properly cited.
America. This is an Open Access article distributed under the terms of the Creative Commons Attribution
License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and
reproduction in any medium, provided the original work is properly cited.
License URL
Publication Status
Published
Date Publish Online
2023-04-20